Yaushe Supernus Pharmaceuticals, Inc. ya wallafa wata sanarwa da asara?
Rahotanni na Supernus Pharmaceuticals, Inc. da kuma asarar da aka wallafa sau ɗaya a cikin kwata, an wallafa asusun ajiyar kuɗi na Supernus Pharmaceuticals, Inc. a ranar 31/03/2021.
Mene ne riba daga hannun jari na Supernus Pharmaceuticals, Inc.?
Abinda aka kiyasta ta hannun Supernus Pharmaceuticals, Inc. ya kasance 0.11 $ a cikin rahoton kudi na ƙarshe.
Yaushe Supernus Pharmaceuticals, Inc. zai buga bayanan asara da asarar gaba?
Rahoton na gaba akan asusun riba da asarar Supernus Pharmaceuticals, Inc. zai kasance ranar Yuni 2024.
Supernus Pharmaceuticals, Inc. albashin da kaso na kungiyar hada-hadar kudade ke lissafa ne na nasarar kamfanin, wanda aka jingina da kimar kungiyar kansa. Ana tara albashi da kaso gwargwadon tsari: adadin ribar da kamfanin ya samu na lokacin hada-hadar gwargwadon rahoton aikin hukuma an rarrabe shi da adadin hannun jari a kamfanin. Supernus Pharmaceuticals, Inc. ana tara albashi ta kowane bangare akan kowane tazara na kudi. Riba na Supernus Pharmaceuticals, Inc. - ribar da kungiyar ta bayar na tazara ta hanyar da doka ta tanada.
|
Riba Supernus Pharmaceuticals, Inc.
Supernus Pharmaceuticals, Inc. riba mai tsoka ne don tunani kawai kuma ba shi da ban sha'awa ga masu hannun jeri. Mafi nuna alama mai ban sha'awa ita ce riba ta kowace kashi, wanda kai tsaye ke rinjayar adadin rabon kowane rabo. Ranar da aka sanya kudin shiga na Supernus Pharmaceuticals, Inc. doka ce da dokokin kungiyar. Kwancen Supernus Pharmaceuticals, Inc. maganganun riba don lokutan kwanan nan ana nuna su a tebur da zane na sabis ɗinmu na kan layi.
|
Bincike na hamsin Supernus Pharmaceuticals, Inc.
Abubuwan da suka samu ta hanyar Supernus Pharmaceuticals, Inc. an kirga su daidai da tsarin da aka samu: kudin shiga da ya raba hannun jarin duk hannun jari a kamfanin. Ana samun albashi ta kashin Supernus Pharmaceuticals, Inc. ana la'akari da shi na wani lokacin kudi sannan kuma ana bayar da rahoton rahoton kuɗi akan ribar kamfanin gaba ɗaya. Supernus Pharmaceuticals, Inc. albashin kowane rashi na yau ko don nazara tazara zata iya gani a saman tebur. Profitwararrun riba Supernus Pharmaceuticals, Inc. shine mafi yawan nau'ikan rahoton rahoton kuɗi don ƙididdigar kuɗi.
|
|
SUPN rahoton kwanan wata
|
Raba ta kashi
Ana kiyasta yawan kuɗin da aka raba ta hanyar rarraba kudaden shiga (ko riba) ta yawan adadin kamfanonin kamfanin.
|
Canja don shekara %
|
|
31/03/2021 |
0.11 USD |
- |
|
31/12/2020 |
0.57 USD |
- |
|
30/09/2020 |
0.74 USD |
+37.04% ↑ |
|
30/06/2020 |
0.65 USD |
+6.56% ↑ |
|
30/09/2019 |
0.54 USD |
+47.06% ↑ |
|
30/06/2019 |
0.61 USD |
+34.88% ↑ |
|
31/03/2019 |
0.34 USD |
+44.06% ↑ |
|
31/12/2018 |
0.48 USD |
- |
|
30/09/2018 |
0.52 USD |
+49.72% ↑ |
|
30/06/2018 |
0.57 USD |
+79.17% ↑ |
|
31/03/2018 |
0.49 USD |
+49.66% ↑ |
|
31/12/2017 |
0.44 USD |
+8% ↑ |
|
30/09/2017 |
0.29 USD |
-25.384% ↓ |
|
30/06/2017 |
0.32 USD |
+82.61% ↑ |
|
31/03/2017 |
0.19 USD |
+146.13% ↑ |
|
31/12/2016 |
0.26 USD |
+306.97% ↑ |
|
30/09/2016 |
0.37 USD |
+1 364.510% ↑ |
|
30/06/2016 |
0.18 USD |
+447.63% ↑ |
|
31/03/2016 |
0.08 USD |
-985.7% ↓ |
|
31/12/2015 |
0.14 USD |
-149.144% ↓ |
|
30/09/2015 |
0.08 USD |
-1443.08% ↓ |
|
30/06/2015 |
0.03 USD |
-115.484% ↓ |
|
31/03/2015 |
0.02 USD |
-97.581% ↓ |
|
31/12/2014 |
0.1 USD |
-77.355% ↓ |
|
30/09/2014 |
0.39 USD |
-153.731% ↓ |
|
30/06/2014 |
0.08 USD |
-76.275% ↓ |
|
31/03/2014 |
-0.35 USD |
-41.785% ↓ |
|
31/12/2013 |
-0.39 USD |
-22.0702% ↓ |
|
30/09/2013 |
-0.64 USD |
-7.96% ↓ |
|
30/06/2013 |
-0.57 USD |
-26.0205% ↓ |
|
31/03/2013 |
-0.6 USD |
-42.0408% ↓ |
|
31/12/2012 |
-0.51 USD |
- |
|
30/09/2012 |
-0.55 USD |
- |
|
30/06/2012 |
-0.61 USD |
- |
|
31/03/2012 |
-6.05 USD |
- |
Supernus Pharmaceuticals, Inc. Albashin da ya samu na kwata-kwata a kashi ɗaya wani kaso ne na ribar kamfanin. Amma an kasa buƙata fiye da riba na shekara akan rabon ɗaya. Profitarshen kwata na ƙarshe Supernus Pharmaceuticals, Inc. na yau yana ɗaukar ribar da aka buga don kwata na ƙarshen kwata. Canjin ribar Supernus Pharmaceuticals, Inc. na shekara an lissafta shi ne idan aka kwatanta da irin lokacin kuɗin da aka yi daidai da mai nuna halin yanzu kawai na shekarar da ta gabata. Canjin kashi ɗaya bisa ɗari na Supernus Pharmaceuticals, Inc. ƙarancin ƙima darajar dangane da canjin ribar shekara-shekara na Supernus Pharmaceuticals, Inc..
An nuna canjin riba a matsayin kashi. A cikin teburin sabis ɗin Ribar da ke kan wannan shafin, zaku iya samun tarihin Supernus Pharmaceuticals, Inc. riba na lokutan rahoton da suka gabata, don bara ko wani tazara. Supernus Pharmaceuticals, Inc. Tarihin samun kuɗaɗen shiga yana samuwa akan layi kowace shekara da kwata cikin shekaru goma da suka gabata. The Supernus Pharmaceuticals, Inc. cibiyar tattara ribar kamfanin na shekarun da suka gabata ana samun su daga hanyoyin buɗe.
|
